![Ayman El-Guindy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ayman El-Guindy is currently the Chief Scientific Officer at Viracta Therapeutics, Inc. Previously, he worked as an Associate Professor at Yale School of Medicine.
He received his graduate and doctorate degrees from Yale University and his graduate degree from Ain Shams University.
| Companies | Position | Start |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-07-05 |
| Companies | Position | End |
|---|---|---|
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ain Shams University
 Ain Shams University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
